Chrysemys picta bellii isolate RCT428 chromosome 15, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM002666.2.\nOn Aug 10, 2021 this sequence version replaced NC_024229.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
corticosteroid 11-beta-dehydrogenase isozyme 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
solute carrier family 9 member A5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
solute carrier family 9 member A5, transcript variant X2
solute carrier family 9 member A5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G4, transcript variant X4
pleckstrin homology and RhoGEF domain containing G4, transcript variant X1
pleckstrin homology and RhoGEF domain containing G4, transcript variant X3
pleckstrin homology and RhoGEF domain containing G4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 36
tubulin polymerization promoting protein family member 3, transcript variant X1
tubulin polymerization promoting protein family member 3, transcript variant X2
tubulin polymerization-promoting protein family member 3
zinc finger DHHC-type containing 1, transcript variant X4
zinc finger DHHC-type containing 1, transcript variant X3
zinc finger DHHC-type containing 1, transcript variant X2
zinc finger DHHC-type containing 1, transcript variant X1
zinc finger DHHC-type containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
zinc finger DHHC-type containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
solute carrier family 38 member 7, transcript variant X2
solute carrier family 38 member 7, transcript variant X1
putative sodium-coupled neutral amino acid transporter 7
CCR4-NOT transcription complex subunit 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 1, transcript variant X1
CCR4-NOT transcription complex subunit 1, transcript variant X8
CCR4-NOT transcription complex subunit 1, transcript variant X5
CCR4-NOT transcription complex subunit 1, transcript variant X7
CCR4-NOT transcription complex subunit 1, transcript variant X6
CCR4-NOT transcription complex subunit 1, transcript variant X4
CCR4-NOT transcription complex subunit 1, transcript variant X3
CCR4-NOT transcription complex subunit 1, transcript variant X10
CCR4-NOT transcription complex subunit 1, transcript variant X2
CCR4-NOT transcription complex subunit 1, transcript variant X9
CCR4-NOT transcription complex subunit 1 isoform X1
CCR4-NOT transcription complex subunit 1 isoform X8
CCR4-NOT transcription complex subunit 1 isoform X5
CCR4-NOT transcription complex subunit 1 isoform X10
CCR4-NOT transcription complex subunit 1 isoform X3
CCR4-NOT transcription complex subunit 1 isoform X7
CCR4-NOT transcription complex subunit 1 isoform X2
CCR4-NOT transcription complex subunit 1 isoform X6
CCR4-NOT transcription complex subunit 1 isoform X4
CCR4-NOT transcription complex subunit 1 isoform X9
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00404
SET domain containing 6, protein lysine methyltransferase, transcript variant X1
SET domain containing 6, protein lysine methyltransferase, transcript variant X2
N-lysine methyltransferase SETD6 isoform X2
N-lysine methyltransferase SETD6 isoform X1
NDRG family member 4, transcript variant X3
NDRG family member 4, transcript variant X1
NDRG family member 4, transcript variant X2
NDRG family member 4, transcript variant X4
GINS complex subunit 3, transcript variant X2
GINS complex subunit 3, transcript variant X1
DNA replication complex GINS protein PSF3 isoform X2
DNA replication complex GINS protein PSF3 isoform X1
diacylglycerol O-acyltransferase 1-like, transcript variant X1
diacylglycerol O-acyltransferase 1-like, transcript variant X2
diacylglycerol O-acyltransferase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
diacylglycerol O-acyltransferase 1-like, transcript variant X3
diacylglycerol O-acyltransferase 1-like, transcript variant X7
diacylglycerol O-acyltransferase 1-like isoform X1
diacylglycerol O-acyltransferase 1-like isoform X2
diacylglycerol O-acyltransferase 1-like, transcript variant X4
diacylglycerol O-acyltransferase 1-like, transcript variant X9
diacylglycerol O-acyltransferase 1-like isoform X3
diacylglycerol O-acyltransferase 1-like isoform X4
diacylglycerol O-acyltransferase 1-like, transcript variant X6
diacylglycerol O-acyltransferase 1-like, transcript variant X8
diacylglycerol O-acyltransferase 1-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain containing 113, transcript variant X2
coiled-coil domain containing 113, transcript variant X1
coiled-coil domain-containing protein 113 isoform X2
coiled-coil domain-containing protein 113 isoform X1
cilia and flagella associated protein 20
cilia- and flagella-associated protein 20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
testis, prostate and placenta expressed, transcript variant X3
testis, prostate and placenta expressed, transcript variant X5
testis, prostate and placenta expressed, transcript variant X2
testis, prostate and placenta-expressed protein isoform X4
testis, prostate and placenta-expressed protein isoform X2
testis, prostate and placenta expressed, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
testis, prostate and placenta expressed, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
testis, prostate and placenta-expressed protein isoform X3
testis, prostate and placenta-expressed protein isoform X1
cyclic nucleotide-gated cation channel beta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
cyclic nucleotide gated channel subunit beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclic nucleotide gated channel subunit beta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclic nucleotide gated channel subunit beta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclic nucleotide-gated cation channel beta-1 isoform X1
cyclic nucleotide-gated cation channel beta-1 isoform X2
kinesin family member C3, transcript variant X5
kinesin family member C3, transcript variant X6
kinesin family member C3, transcript variant X4
kinesin family member C3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kinesin family member C3, transcript variant X1
kinesin family member C3, transcript variant X2
kinesin family member C3, transcript variant X7
katanin regulatory subunit B1, transcript variant X3
katanin regulatory subunit B1, transcript variant X1
katanin regulatory subunit B1, transcript variant X2
katanin p80 WD40 repeat-containing subunit B1
dynein regulatory complex subunit 7, transcript variant X2
dynein regulatory complex subunit 7, transcript variant X3
dynein regulatory complex subunit 7, transcript variant X1
dynein regulatory complex subunit 7 isoform X2
dynein regulatory complex subunit 7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
proteasome 26S subunit, non-ATPase 7, transcript variant X1
26S proteasome non-ATPase regulatory subunit 7 isoform X1
proteasome 26S subunit, non-ATPase 7, transcript variant X2
26S proteasome non-ATPase regulatory subunit 7 isoform X2
WW domain containing E3 ubiquitin protein ligase 2
NEDD4-like E3 ubiquitin-protein ligase WWP2
NIN1 (RPN12) binding protein 1 homolog, transcript variant X1
NIN1 (RPN12) binding protein 1 homolog, transcript variant X2
nuclear factor of activated T cells 5, transcript variant X4
nuclear factor of activated T cells 5, transcript variant X1
nuclear factor of activated T cells 5, transcript variant X3
nuclear factor of activated T cells 5, transcript variant X2
nuclear factor of activated T cells 5, transcript variant X6
nuclear factor of activated T cells 5, transcript variant X5
nuclear factor of activated T cells 5, transcript variant X7
nuclear factor of activated T cells 5, transcript variant X9
nuclear factor of activated T cells 5, transcript variant X8
nuclear factor of activated T-cells 5 isoform X4
nuclear factor of activated T-cells 5 isoform X1
nuclear factor of activated T-cells 5 isoform X2
nuclear factor of activated T-cells 5 isoform X3
nuclear factor of activated T-cells 5 isoform X6
nuclear factor of activated T-cells 5 isoform X5
nuclear factor of activated T-cells 5 isoform X7
telomeric repeat binding factor 2, transcript variant X2
telomeric repeat binding factor 2, transcript variant X1
telomeric repeat binding factor 2, transcript variant X3
telomeric repeat-binding factor 2 isoform X1
telomeric repeat-binding factor 2 isoform X3
telomeric repeat-binding factor 2 isoform X2
telomeric repeat binding factor 2, transcript variant X4
telomeric repeat binding factor 2, transcript variant X5
telomeric repeat-binding factor 2 isoform X4
telomeric repeat-binding factor 2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transmembrane emp24 domain-containing protein 6
nucleolar pre-rRNA processing protein NIP7
60S ribosome subunit biogenesis protein NIP7 homolog
component of oligomeric golgi complex 8, transcript variant X2
component of oligomeric golgi complex 8, transcript variant X1
conserved oligomeric Golgi complex subunit 8 isoform X2
conserved oligomeric Golgi complex subunit 8 isoform X1
vacuolar protein sorting-associated protein 4A
uncharacterized LOC122173899, transcript variant X1
uncharacterized LOC122173899, transcript variant X3
uncharacterized LOC122173899, transcript variant X2
uncharacterized LOC122173899, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UTP4 small subunit processome component, transcript variant X1
U3 small nucleolar RNA-associated protein 4 homolog isoform X1
UTP4 small subunit processome component, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
U3 small nucleolar RNA-associated protein 4 homolog isoform X2
chromosome transmission fidelity factor 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
chromosome transmission fidelity factor 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
chromosome transmission fidelity factor 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
chromosome transmission fidelity protein 8 homolog
DERPC proline and glycine rich nuclear protein, transcript variant X1
DERPC proline and glycine rich nuclear protein, transcript variant X2
DERPC proline and glycine rich nuclear protein, transcript variant X3
decreased expression in renal and prostate cancer protein isoform X1
decreased expression in renal and prostate cancer protein isoform X2
decreased expression in renal and prostate cancer protein isoform X3
hyaluronan synthase 3, transcript variant X1
hyaluronan synthase 3, transcript variant X2
transport and golgi organization 6 homolog, transcript variant X5
transport and golgi organization 6 homolog, transcript variant X4
transport and golgi organization 6 homolog, transcript variant X3
transport and golgi organization 6 homolog, transcript variant X7
transport and golgi organization 6 homolog, transcript variant X2
transport and golgi organization 6 homolog, transcript variant X1
transport and Golgi organization protein 6 homolog isoform X4
transport and Golgi organization protein 6 homolog isoform X3
transport and Golgi organization protein 6 homolog isoform X7
transport and Golgi organization protein 6 homolog isoform X2
transport and Golgi organization protein 6 homolog isoform X1
transport and Golgi organization protein 6 homolog isoform X5
transport and golgi organization 6 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transport and Golgi organization protein 6 homolog isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
growth arrest specific 8, transcript variant X2
growth arrest specific 8, transcript variant X1
dynein regulatory complex subunit 4 isoform X1
dynein regulatory complex subunit 4 isoform X2
AFG3-like protein 1, transcript variant X1
AFG3-like protein 1, transcript variant X2
AFG3-like protein 1, transcript variant X3
differentially expressed in FDCP 8 homolog, transcript variant X3
differentially expressed in FDCP 8 homolog, transcript variant X1
differentially expressed in FDCP 8 homolog, transcript variant X2
differentially expressed in FDCP 8 homolog isoform X2
differentially expressed in FDCP 8 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
transcription factor 25, transcript variant X1
ankyrin repeat domain 11, transcript variant X1
ankyrin repeat domain 11, transcript variant X2
ankyrin repeat domain 11, transcript variant X3
ankyrin repeat domain 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ankyrin repeat domain 11, transcript variant X4
ankyrin repeat domain 11, transcript variant X8
ankyrin repeat domain 11, transcript variant X5
ankyrin repeat domain 11, transcript variant X7
ankyrin repeat domain-containing protein 11 isoform X1
ankyrin repeat domain-containing protein 11 isoform X2
ankyrin repeat domain-containing protein 11 isoform X3
ankyrin repeat domain-containing protein 11 isoform X5
ankyrin repeat domain-containing protein 11 isoform X4
ankyrin repeat domain-containing protein 11 isoform X7
ankyrin repeat domain-containing protein 11 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
putative solute carrier family 22 member 31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X1
malonate--CoA ligase ACSF3, mitochondrial isoform X5
acyl-CoA synthetase family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X4
acyl-CoA synthetase family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X7
malonate--CoA ligase ACSF3, mitochondrial isoform X3
acyl-CoA synthetase family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CBFA2/RUNX1 partner transcriptional co-repressor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
embryonic polyadenylate-binding protein 2
trafficking protein particle complex subunit 2L
trafficking protein particle complex subunit 2-like protein
galactosamine (N-acetyl)-6-sulfatase, transcript variant X1
N-acetylgalactosamine-6-sulfatase isoform X1
galactosamine (N-acetyl)-6-sulfatase, transcript variant X2
N-acetylgalactosamine-6-sulfatase isoform X2
chromatin licensing and DNA replication factor 1, transcript variant X2
chromatin licensing and DNA replication factor 1, transcript variant X1
piezo type mechanosensitive ion channel component 1, transcript variant X1
piezo type mechanosensitive ion channel component 1, transcript variant X3
piezo type mechanosensitive ion channel component 1, transcript variant X5
piezo type mechanosensitive ion channel component 1, transcript variant X2
piezo-type mechanosensitive ion channel component 1 isoform X1
piezo-type mechanosensitive ion channel component 1 isoform X3
piezo-type mechanosensitive ion channel component 1 isoform X5
piezo-type mechanosensitive ion channel component 1 isoform X2
piezo type mechanosensitive ion channel component 1, transcript variant X4
piezo-type mechanosensitive ion channel component 1 isoform X4
piezo type mechanosensitive ion channel component 1, transcript variant X6
piezo-type mechanosensitive ion channel component 1 isoform X6
cytosolic thiouridylase subunit 2, transcript variant X2
cytosolic thiouridylase subunit 2, transcript variant X1
cytoplasmic tRNA 2-thiolation protein 2 isoform X1
cytoplasmic tRNA 2-thiolation protein 2 isoform X2
ring finger protein 166, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ring finger protein 166, transcript variant X2
ring finger protein 166, transcript variant X4
ring finger protein 166, transcript variant X1
snail family transcriptional repressor 3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger CCCH-type containing 18, transcript variant X2
zinc finger CCCH-type containing 18, transcript variant X6
zinc finger CCCH-type containing 18, transcript variant X5
zinc finger CCCH-type containing 18, transcript variant X3
zinc finger CCCH-type containing 18, transcript variant X1
zinc finger CCCH-type containing 18, transcript variant X4
zinc finger CCCH domain-containing protein 18 isoform X3
zinc finger CCCH domain-containing protein 18 isoform X5
zinc finger CCCH domain-containing protein 18 isoform X4
zinc finger CCCH domain-containing protein 18 isoform X2
zinc finger CCCH domain-containing protein 18 isoform X1
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cell death inducing DFFA like effector c, transcript variant X1
cell death inducing DFFA like effector c, transcript variant X2
zinc finger protein, FOG family member 1, transcript variant X2
zinc finger protein, FOG family member 1, transcript variant X1
zinc finger protein, FOG family member 1, transcript variant X4
zinc finger protein, FOG family member 1, transcript variant X3
uncharacterized LOC122173901, transcript variant X1
uncharacterized LOC122173901, transcript variant X2
zinc finger protein 469, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 469, transcript variant X1
BTG3 associated nuclear protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
carbonic anhydrase 5A, transcript variant X2
carbonic anhydrase 5A, mitochondrial isoform X2
carbonic anhydrase 5A, transcript variant X1
carbonic anhydrase 5A, mitochondrial isoform X1
carbonic anhydrase 5A, transcript variant X3
carbonic anhydrase 5A, mitochondrial isoform X3
large neutral amino acids transporter small subunit 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: kelch domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCHC-type containing 14, transcript variant X2
zinc finger CCHC-type containing 14, transcript variant X1
zinc finger CCHC domain-containing protein 14 isoform X2
zinc finger CCHC domain-containing protein 14 isoform X1
microtubule associated protein 1 light chain 3 beta
microtubule-associated proteins 1A/1B light chain 3B
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
KIAA0513 ortholog, transcript variant X2
KIAA0513 ortholog, transcript variant X5
KIAA0513 ortholog, transcript variant X6
KIAA0513 ortholog, transcript variant X1
KIAA0513 ortholog, transcript variant X4
KIAA0513 ortholog, transcript variant X3
uncharacterized protein KIAA0513 homolog isoform X1
uncharacterized protein KIAA0513 homolog isoform X2
uncharacterized protein KIAA0513 homolog isoform X3
extracellular calcium-sensing receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CBY1 interacting BAR domain containing 2, transcript variant X4
CBY1 interacting BAR domain containing 2, transcript variant X2
CBY1 interacting BAR domain containing 2, transcript variant X1
CBY1 interacting BAR domain containing 2, transcript variant X3
CBY1-interacting BAR domain-containing protein 2 isoform X2
CBY1-interacting BAR domain-containing protein 2 isoform X4
CBY1-interacting BAR domain-containing protein 2 isoform X1
CBY1-interacting BAR domain-containing protein 2 isoform X3
Gse1 coiled-coil protein, transcript variant X3
Gse1 coiled-coil protein, transcript variant X1
Gse1 coiled-coil protein, transcript variant X2
DNA replication complex GINS protein PSF2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X4
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X5
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X3
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X6
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X2
dual specificity protein phosphatase 22-A-like, transcript variant X1
dual specificity protein phosphatase 22-A-like, transcript variant X2
dual specificity protein phosphatase 22-A-like
methenyltetrahydrofolate synthetase domain containing, transcript variant X3
methenyltetrahydrofolate synthetase domain containing, transcript variant X4
methenyltetrahydrofolate synthetase domain containing, transcript variant X1
methenyltetrahydrofolate synthetase domain containing, transcript variant X2
methenyltetrahydrofolate synthetase domain containing, transcript variant X5
methenyltetrahydrofolate synthetase domain containing, transcript variant X6
methenyltetrahydrofolate synthase domain-containing protein isoform X3
methenyltetrahydrofolate synthase domain-containing protein isoform X4
methenyltetrahydrofolate synthase domain-containing protein isoform X1
methenyltetrahydrofolate synthase domain-containing protein isoform X2
methenyltetrahydrofolate synthase domain-containing protein isoform X5
methenyltetrahydrofolate synthase domain-containing protein isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
V-type proton ATPase 21 kDa proteolipid subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC101950492, transcript variant X2
uncharacterized LOC101950492, transcript variant X1
uncharacterized protein LOC101950492 isoform X2
uncharacterized protein LOC101950492 isoform X1
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X2
hepatocyte nuclear factor 4-beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hepatocyte nuclear factor 4-beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hepatocyte nuclear factor 4-beta-like isoform X2
hepatocyte nuclear factor 4-beta-like isoform X1
cysteine rich secretory protein LCCL domain containing 2, transcript variant X2
cysteine rich secretory protein LCCL domain containing 2, transcript variant X1
cysteine rich secretory protein LCCL domain containing 2, transcript variant X3
cysteine-rich secretory protein LCCL domain-containing 2
ubiquitin specific peptidase 10, transcript variant X4
ubiquitin specific peptidase 10, transcript variant X3
ubiquitin specific peptidase 10, transcript variant X5
ubiquitin specific peptidase 10, transcript variant X2
ubiquitin specific peptidase 10, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 10 isoform X4
ubiquitin carboxyl-terminal hydrolase 10 isoform X3
ubiquitin carboxyl-terminal hydrolase 10 isoform X5
ubiquitin carboxyl-terminal hydrolase 10 isoform X2
ubiquitin carboxyl-terminal hydrolase 10 isoform X1
kelch like family member 36, transcript variant X4
kelch like family member 36, transcript variant X2
kelch like family member 36, transcript variant X3
kelch like family member 36, transcript variant X1
coactosin like F-actin binding protein 1
MTOR associated protein, eak-7 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
MTOR associated protein, eak-7 homolog, transcript variant X1
MTOR-associated protein MEAK7 isoform X1
MTOR-associated protein MEAK7 isoform X2
ATPase secretory pathway Ca2+ transporting 2
calcium-transporting ATPase type 2C member 2
WAP four-disulfide core domain 1, transcript variant X4
WAP four-disulfide core domain 1, transcript variant X3
WAP four-disulfide core domain 1, transcript variant X2
WAP four-disulfide core domain 1, transcript variant X1
WAP four-disulfide core domain protein 1 isoform X4
WAP four-disulfide core domain protein 1 isoform X2
WAP four-disulfide core domain protein 1 isoform X3
WAP four-disulfide core domain protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily G member 4
malonyl-CoA decarboxylase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
arylamine N-acetyltransferase, pineal gland isozyme NAT-10-like
arylamine N-acetyltransferase, pineal gland isozyme NAT-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X2
17-beta-hydroxysteroid dehydrogenase type 2
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X1
short-chain dehydrogenase/reductase family 42E member 1
phospholipase C gamma 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phospholipase C gamma 2, transcript variant X1
phospholipase C gamma 2, transcript variant X2
phospholipase C gamma 2, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
phospholipase C gamma 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
c-Maf inducing protein, transcript variant X2
c-Maf inducing protein, transcript variant X1
c-Maf inducing protein, transcript variant X3
c-Maf inducing protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-carotene oxygenase 1, transcript variant X4
beta-carotene oxygenase 1, transcript variant X3
beta-carotene oxygenase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
beta,beta-carotene 15,15'-dioxygenase isoform X1
beta,beta-carotene 15,15'-dioxygenase isoform X3
beta,beta-carotene 15,15'-dioxygenase isoform X4
beta-carotene oxygenase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
beta,beta-carotene 15,15'-dioxygenase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
polycystic kidney disease protein 1-like 2
glycine cleavage system protein H, transcript variant X1
glycine cleavage system H protein, mitochondrial isoform X1
glycine cleavage system protein H, transcript variant X2
glycine cleavage system H protein, mitochondrial isoform X2
protein phosphatase 1 regulatory subunit 3E-like
chromosome 15 C16orf46 homolog, transcript variant X1
chromosome 15 C16orf46 homolog, transcript variant X2
uncharacterized protein C16orf46 homolog
C-X9-C motif containing 2, transcript variant X2
C-X9-C motif containing 2, transcript variant X1
COX assembly mitochondrial protein 2 homolog isoform X1
COX assembly mitochondrial protein 2 homolog isoform X2
dynein light chain roadblock-type 2, transcript variant X1
dynein light chain roadblock-type 2, transcript variant X2
dynein light chain roadblock-type 2 isoform X1
dynein light chain roadblock-type 2 isoform X2
MAF bZIP transcription factor, transcript variant X2
MAF bZIP transcription factor, transcript variant X1
MAF bZIP transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
WW domain containing oxidoreductase, transcript variant X1
WW domain containing oxidoreductase, transcript variant X2
WW domain-containing oxidoreductase isoform X1
WW domain-containing oxidoreductase isoform X2
uncharacterized LOC112059880, transcript variant X1
uncharacterized LOC112059880, transcript variant X2
WW domain containing oxidoreductase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
WW domain-containing oxidoreductase isoform X3
uncharacterized LOC112059879, transcript variant X1
uncharacterized LOC112059879, transcript variant X2
uncharacterized protein LOC112059879 isoform X2
uncharacterized protein LOC112059879 isoform X1
vesicle amine transport 1 like, transcript variant X2
vesicle amine transport 1 like, transcript variant X1
synaptic vesicle membrane protein VAT-1 homolog-like isoform X2
synaptic vesicle membrane protein VAT-1 homolog-like isoform X1
nudix hydrolase 7, transcript variant X1
nudix hydrolase 7, transcript variant X3
nudix hydrolase 7, transcript variant X2
nudix hydrolase 7, transcript variant X4
peroxisomal coenzyme A diphosphatase NUDT7 isoform X2
peroxisomal coenzyme A diphosphatase NUDT7 isoform X1
peroxisomal coenzyme A diphosphatase NUDT7 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 18
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
brain expressed associated with NEDD4 1, transcript variant X1
brain expressed associated with NEDD4 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
thymidine kinase 2, transcript variant X3
thymidine kinase 2, transcript variant X2
thymidine kinase 2, transcript variant X1
thymidine kinase 2, transcript variant X4
thymidine kinase 2, mitochondrial isoform X3
thymidine kinase 2, mitochondrial isoform X2
thymidine kinase 2, mitochondrial isoform X1
thymidine kinase 2, mitochondrial isoform X4
CKLF like MARVEL transmembrane domain containing 3
CKLF-like MARVEL transmembrane domain-containing protein 3
CKLF like MARVEL transmembrane domain containing 4, transcript variant X3
CKLF like MARVEL transmembrane domain containing 4, transcript variant X2
CKLF like MARVEL transmembrane domain containing 4, transcript variant X1
CKLF-like MARVEL transmembrane domain-containing protein 4
dynein cytoplasmic 1 light intermediate chain 2, transcript variant X1
dynein cytoplasmic 1 light intermediate chain 2, transcript variant X2
cytoplasmic dynein 1 light intermediate chain 2 isoform X1
cytoplasmic dynein 1 light intermediate chain 2 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
telomere repeat binding bouquet formation protein 1
telomere repeats-binding bouquet formation protein 1
NEDD8 activating enzyme E1 subunit 1, transcript variant X2
NEDD8 activating enzyme E1 subunit 1, transcript variant X1
NEDD8-activating enzyme E1 regulatory subunit isoform X1
NEDD8-activating enzyme E1 regulatory subunit isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X1
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X2
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 2, mitochondrial
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
cytosolic iron-sulfur assembly component 2B
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain isoform X3
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain isoform X1
fatty acyl-CoA hydrolase precursor, medium chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fatty acyl-CoA hydrolase precursor, medium chain isoform X2
fatty acyl-CoA hydrolase precursor, medium chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
programmed cell death 2 like, transcript variant X2
programmed cell death protein 2-like isoform X2
programmed cell death 2 like, transcript variant X4
programmed cell death 2 like, transcript variant X3
programmed cell death 2 like, transcript variant X1
programmed cell death protein 2-like isoform X1
programmed cell death protein 2-like isoform X3
programmed cell death protein 2-like isoform X4
uncharacterized LOC122173906, transcript variant X2
uncharacterized LOC122173906, transcript variant X1
ubiquitin like modifier activating enzyme 2
LOW QUALITY PROTEIN: SUMO-activating enzyme subunit 2
WT1 interacting protein, transcript variant X1
WT1 interacting protein, transcript variant X2
Wilms tumor protein 1-interacting protein isoform X1
Wilms tumor protein 1-interacting protein isoform X2
WT1 interacting protein, transcript variant X3
Wilms tumor protein 1-interacting protein isoform X3
granule associated Rac and RHOG effector 1, transcript variant X1
granule associated Rac and RHOG effector 1, transcript variant X3
granule associated Rac and RHOG effector 1, transcript variant X4
granule associated Rac and RHOG effector 1, transcript variant X5
granule associated Rac and RHOG effector 1, transcript variant X2
granule associated Rac and RHOG effector protein 1 isoform X4
granule associated Rac and RHOG effector protein 1 isoform X1
granule associated Rac and RHOG effector protein 1 isoform X2
granule associated Rac and RHOG effector protein 1 isoform X3
LSM14A mRNA processing body assembly factor, transcript variant X4
LSM14A mRNA processing body assembly factor, transcript variant X3
LSM14A mRNA processing body assembly factor, transcript variant X2
LSM14A mRNA processing body assembly factor, transcript variant X1
transcription initiation factor TFIID subunit 4-like, transcript variant X1
transcription initiation factor TFIID subunit 4-like, transcript variant X2
transcription initiation factor TFIID subunit 4-like, transcript variant X3
transcription initiation factor TFIID subunit 4-like isoform X1
transcription initiation factor TFIID subunit 4-like isoform X2
potassium channel tetramerization domain containing 15, transcript variant X1
potassium channel tetramerization domain containing 15, transcript variant X4
potassium channel tetramerization domain containing 15, transcript variant X2
potassium channel tetramerization domain containing 15, transcript variant X6
potassium channel tetramerization domain containing 15, transcript variant X9
potassium channel tetramerization domain containing 15, transcript variant X10
potassium channel tetramerization domain containing 15, transcript variant X12
potassium channel tetramerization domain containing 15, transcript variant X3
potassium channel tetramerization domain containing 15, transcript variant X11
potassium channel tetramerization domain containing 15, transcript variant X5
potassium channel tetramerization domain containing 15, transcript variant X13
potassium channel tetramerization domain containing 15, transcript variant X8
potassium channel tetramerization domain containing 15, transcript variant X15
potassium channel tetramerization domain containing 15, transcript variant X14
potassium channel tetramerization domain containing 15, transcript variant X7
BTB/POZ domain-containing protein KCTD15 isoform X1
BTB/POZ domain-containing protein KCTD15 isoform X4
BTB/POZ domain-containing protein KCTD15 isoform X2
BTB/POZ domain-containing protein KCTD15 isoform X3
BTB/POZ domain-containing protein KCTD15 isoform X5
carbohydrate sulfotransferase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
carbohydrate sulfotransferase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
carbohydrate sulfotransferase 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
carbohydrate sulfotransferase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
carbohydrate sulfotransferase 8 isoform X2
carbohydrate sulfotransferase 8 isoform X1
carbohydrate sulfotransferase 8 isoform X4
carbohydrate sulfotransferase 8 isoform X3
carbohydrate sulfotransferase 8, transcript variant X5
uncharacterized LOC101953210, transcript variant X1
uncharacterized LOC101953210, transcript variant X2
uncharacterized LOC122173909, transcript variant X3
uncharacterized LOC122173909, transcript variant X1
uncharacterized LOC122173909, transcript variant X2
uncharacterized LOC122173909, transcript variant X4
CCAAT enhancer binding protein gamma, transcript variant X1
CCAAT enhancer binding protein gamma, transcript variant X2
LDL receptor related protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
LDL receptor related protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 3 isoform X2
low-density lipoprotein receptor-related protein 3 isoform X1
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
G-patch domain containing 1, transcript variant X1
G-patch domain containing 1, transcript variant X2
G patch domain-containing protein 1 isoform X2
G patch domain-containing protein 1 isoform X1
G-patch domain containing 1, transcript variant X3
G patch domain-containing protein 1 isoform X3
rhophilin Rho GTPase binding protein 2, transcript variant X2
rhophilin Rho GTPase binding protein 2, transcript variant X1
FA core complex associated protein 24, transcript variant X2
FA core complex associated protein 24, transcript variant X1
Fanconi anemia core complex-associated protein 24 isoform X1
Fanconi anemia core complex-associated protein 24 isoform X2
centrosomal protein 89, transcript variant X1
centrosomal protein 89, transcript variant X3
centrosomal protein of 89 kDa isoform X1
centrosomal protein 89, transcript variant X2
centrosomal protein of 89 kDa isoform X2
centrosomal protein of 89 kDa isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 7 member 9, transcript variant X2
solute carrier family 7 member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
putative ATP-dependent RNA helicase TDRD12
LOW QUALITY PROTEIN: nucleoside diphosphate-linked moiety X motif 19
regulator of G protein signaling 9 binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 9-binding protein
ankyrin repeat domain-containing protein 27
neural-cadherin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
neural-cadherin-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dpy-19 like C-mannosyltransferase 3, transcript variant X5
dpy-19 like C-mannosyltransferase 3, transcript variant X3
dpy-19 like C-mannosyltransferase 3, transcript variant X6
dpy-19 like C-mannosyltransferase 3, transcript variant X4
dpy-19 like C-mannosyltransferase 3, transcript variant X1
dpy-19 like C-mannosyltransferase 3, transcript variant X2
probable C-mannosyltransferase DPY19L3 isoform X2
probable C-mannosyltransferase DPY19L3 isoform X5
probable C-mannosyltransferase DPY19L3 isoform X3
probable C-mannosyltransferase DPY19L3 isoform X6
probable C-mannosyltransferase DPY19L3 isoform X4
probable C-mannosyltransferase DPY19L3 isoform X1
dpy-19 like C-mannosyltransferase 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dpy-19 like C-mannosyltransferase 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 507, transcript variant X4
zinc finger protein 507, transcript variant X3
zinc finger protein 507, transcript variant X2
zinc finger protein 507, transcript variant X1
zinc finger protein 507, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 507, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 507, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC101944715, transcript variant X2
uncharacterized LOC101944715, transcript variant X3
uncharacterized LOC101944715, transcript variant X1
uncharacterized LOC101944715, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC101944715, transcript variant X4
teashirt zinc finger homeobox 3, transcript variant X3
teashirt zinc finger homeobox 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
teashirt zinc finger homeobox 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
teashirt zinc finger homeobox 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 536, transcript variant X14
zinc finger protein 536, transcript variant X16
zinc finger protein 536, transcript variant X8
zinc finger protein 536, transcript variant X11
zinc finger protein 536, transcript variant X9
zinc finger protein 536, transcript variant X13
zinc finger protein 536, transcript variant X3
zinc finger protein 536, transcript variant X1
zinc finger protein 536, transcript variant X12
zinc finger protein 536, transcript variant X2
zinc finger protein 536, transcript variant X4
zinc finger protein 536, transcript variant X6
zinc finger protein 536, transcript variant X15
zinc finger protein 536, transcript variant X7
zinc finger protein 536, transcript variant X10
zinc finger protein 536, transcript variant X5
zinc finger protein 536, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger protein 536, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 536, transcript variant X19
URI1 prefoldin like chaperone, transcript variant X6
URI1 prefoldin like chaperone, transcript variant X2
URI1 prefoldin like chaperone, transcript variant X1
URI1 prefoldin like chaperone, transcript variant X4
URI1 prefoldin like chaperone, transcript variant X3
URI1 prefoldin like chaperone, transcript variant X5
unconventional prefoldin RPB5 interactor 1 isoform X3
unconventional prefoldin RPB5 interactor 1 isoform X2
unconventional prefoldin RPB5 interactor 1 isoform X1
unconventional prefoldin RPB5 interactor 1 isoform X4
unconventional prefoldin RPB5 interactor 1 isoform X5
unconventional prefoldin RPB5 interactor 1 isoform X6
chromosome 15 C19orf12 homolog, transcript variant X2
chromosome 15 C19orf12 homolog, transcript variant X3
chromosome 15 C19orf12 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 15 C19orf12 homolog, transcript variant X4
chromosome 15 C19orf12 homolog, transcript variant X6
chromosome 15 C19orf12 homolog, transcript variant X5
pleckstrin homology and FYVE domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
pleckstrin homology and FYVE domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pleckstrin homology and FYVE domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
pleckstrin homology and FYVE domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
pleckstrin homology and FYVE domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pleckstrin homology and FYVE domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
pleckstrin homology domain-containing family F member 1
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X2
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X1
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X5
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X3
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X7
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X4
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X6
ribonuclease P protein subunit p29 isoform X2
ribonuclease P protein subunit p29 isoform X1
ribonuclease P protein subunit p29 isoform X3
V-set and transmembrane domain containing 2B, transcript variant X1
V-set and transmembrane domain containing 2B, transcript variant X2
V-set and transmembrane domain-containing protein 2B
cytochrome b-c1 complex subunit Rieske, mitochondrial
vacuolar protein sorting-associated protein 35
myosin light chain kinase 3, transcript variant X7
myosin light chain kinase 3, transcript variant X8
myosin light chain kinase 3, transcript variant X5
myosin light chain kinase 3, transcript variant X3
myosin light chain kinase 3, transcript variant X2
myosin light chain kinase 3, transcript variant X4
myosin light chain kinase 3, transcript variant X1
myosin light chain kinase 3, transcript variant X6
DnaJ heat shock protein family (Hsp40) member A2
uncharacterized LOC112059377, transcript variant X1
uncharacterized LOC112059377, transcript variant X2
neuropilin and tolloid like 2, transcript variant X7
neuropilin and tolloid like 2, transcript variant X5
neuropilin and tolloid like 2, transcript variant X4
neuropilin and tolloid like 2, transcript variant X6
neuropilin and tolloid like 2, transcript variant X3
neuropilin and tolloid like 2, transcript variant X2
neuropilin and tolloid like 2, transcript variant X1
neuropilin and tolloid-like protein 2 isoform X6
neuropilin and tolloid-like protein 2 isoform X4
neuropilin and tolloid-like protein 2 isoform X3
neuropilin and tolloid-like protein 2 isoform X2
neuropilin and tolloid-like protein 2 isoform X5
neuropilin and tolloid-like protein 2 isoform X1
integrin alpha FG-GAP repeat containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
phosphorylase kinase regulatory subunit beta, transcript variant X1
phosphorylase kinase regulatory subunit beta, transcript variant X2
phosphorylase kinase regulatory subunit beta, transcript variant X4
phosphorylase kinase regulatory subunit beta, transcript variant X3
phosphorylase kinase regulatory subunit beta, transcript variant X5
phosphorylase b kinase regulatory subunit beta isoform X5
phosphorylase b kinase regulatory subunit beta isoform X3
phosphorylase b kinase regulatory subunit beta isoform X1
phosphorylase b kinase regulatory subunit beta isoform X2
phosphorylase b kinase regulatory subunit beta isoform X4
ATP-binding cassette sub-family C member 12, transcript variant X2
ATP-binding cassette sub-family C member 12, transcript variant X1
ATP-binding cassette sub-family C member 12 isoform X2
ATP-binding cassette sub-family C member 12 isoform X1
siah E3 ubiquitin protein ligase 1, transcript variant X1
siah E3 ubiquitin protein ligase 1, transcript variant X5
siah E3 ubiquitin protein ligase 1, transcript variant X4
siah E3 ubiquitin protein ligase 1, transcript variant X3
siah E3 ubiquitin protein ligase 1, transcript variant X2
E3 ubiquitin-protein ligase SIAH1 isoform X1
E3 ubiquitin-protein ligase SIAH1 isoform X2
uncharacterized LOC122173917, transcript variant X1
uncharacterized LOC122173917, transcript variant X2
zinc finger protein 423, transcript variant X2
zinc finger protein 423, transcript variant X7
zinc finger protein 423, transcript variant X1
zinc finger protein 423, transcript variant X6
zinc finger protein 423, transcript variant X10
zinc finger protein 423, transcript variant X8
zinc finger protein 423, transcript variant X3
zinc finger protein 423, transcript variant X4
zinc finger protein 423, transcript variant X5
zinc finger protein 423, transcript variant X9
nuclear receptor coactivator 5-like, transcript variant X5
nuclear receptor coactivator 5-like, transcript variant X3
nuclear receptor coactivator 5-like, transcript variant X4
nuclear receptor coactivator 5-like, transcript variant X2
nuclear receptor coactivator 5-like, transcript variant X6
nuclear receptor coactivator 5-like, transcript variant X1
nuclear receptor coactivator 5-like isoform X5
nuclear receptor coactivator 5-like isoform X3
nuclear receptor coactivator 5-like isoform X4
uncharacterized protein LOC101951213 isoform X6
nuclear receptor coactivator 5-like isoform X1
CTD nuclear envelope phosphatase 1 regulatory subunit 1
nuclear envelope phosphatase-regulatory subunit 1
HEAT repeat containing 3, transcript variant X1
HEAT repeat containing 3, transcript variant X2
HEAT repeat-containing protein 3 isoform X1
HEAT repeat-containing protein 3 isoform X2
terminal nucleotidyltransferase 4B, transcript variant X2
terminal nucleotidyltransferase 4B, transcript variant X1
terminal nucleotidyltransferase 4B isoform X1
terminal nucleotidyltransferase 4B isoform X2
terminal nucleotidyltransferase 4B, transcript variant X3
terminal nucleotidyltransferase 4B isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adenylate cyclase type 7
bromodomain containing 7, transcript variant X7
bromodomain containing 7, transcript variant X6
bromodomain containing 7, transcript variant X5
bromodomain containing 7, transcript variant X4
bromodomain containing 7, transcript variant X8
bromodomain containing 7, transcript variant X3
bromodomain containing 7, transcript variant X2
bromodomain containing 7, transcript variant X1
bromodomain-containing protein 7 isoform X2
bromodomain-containing protein 7 isoform X1
NKD inhibitor of WNT signaling pathway 1, transcript variant X2
NKD inhibitor of WNT signaling pathway 1, transcript variant X1
protein naked cuticle homolog 1 isoform X1
protein naked cuticle homolog 1 isoform X2
NKD inhibitor of WNT signaling pathway 1, transcript variant X3
protein naked cuticle homolog 1 isoform X3
NKD inhibitor of WNT signaling pathway 1, transcript variant X4
protein naked cuticle homolog 1 isoform X4
CYLD lysine 63 deubiquitinase, transcript variant X2
CYLD lysine 63 deubiquitinase, transcript variant X1
CYLD lysine 63 deubiquitinase, transcript variant X3
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
spalt like transcription factor 1, transcript variant X1
spalt like transcription factor 1, transcript variant X2
spalt like transcription factor 1, transcript variant X7
spalt like transcription factor 1, transcript variant X6
spalt like transcription factor 1, transcript variant X4
spalt like transcription factor 1, transcript variant X5
spalt like transcription factor 1, transcript variant X3
uncharacterized LOC101947479, transcript variant X1
uncharacterized LOC101947479, transcript variant X2
TOX high mobility group box family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
TOX high mobility group box family member 3 isoform X2
TOX high mobility group box family member 3 isoform X1
chromodomain helicase DNA binding protein 9, transcript variant X16
chromodomain-helicase-DNA-binding protein 9 isoform X14
chromodomain helicase DNA binding protein 9, transcript variant X2
chromodomain helicase DNA binding protein 9, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X10
chromodomain helicase DNA binding protein 9, transcript variant X5
chromodomain helicase DNA binding protein 9, transcript variant X4
chromodomain helicase DNA binding protein 9, transcript variant X11
chromodomain helicase DNA binding protein 9, transcript variant X3
chromodomain helicase DNA binding protein 9, transcript variant X1
chromodomain helicase DNA binding protein 9, transcript variant X8
chromodomain helicase DNA binding protein 9, transcript variant X6
chromodomain helicase DNA binding protein 9, transcript variant X12
chromodomain helicase DNA binding protein 9, transcript variant X9
chromodomain helicase DNA binding protein 9, transcript variant X7
chromodomain helicase DNA binding protein 9, transcript variant X13
chromodomain helicase DNA binding protein 9, transcript variant X23
chromodomain helicase DNA binding protein 9, transcript variant X17
chromodomain helicase DNA binding protein 9, transcript variant X22
chromodomain helicase DNA binding protein 9, transcript variant X19
chromodomain-helicase-DNA-binding protein 9 isoform X15
chromodomain-helicase-DNA-binding protein 9 isoform X17
chromodomain-helicase-DNA-binding protein 9 isoform X12
chromodomain-helicase-DNA-binding protein 9 isoform X13
chromodomain-helicase-DNA-binding protein 9 isoform X1
chromodomain-helicase-DNA-binding protein 9 isoform X8
chromodomain-helicase-DNA-binding protein 9 isoform X6
chromodomain-helicase-DNA-binding protein 9 isoform X3
chromodomain-helicase-DNA-binding protein 9 isoform X4
chromodomain-helicase-DNA-binding protein 9 isoform X10
chromodomain-helicase-DNA-binding protein 9 isoform X2
chromodomain-helicase-DNA-binding protein 9 isoform X7
chromodomain-helicase-DNA-binding protein 9 isoform X5
chromodomain-helicase-DNA-binding protein 9 isoform X11
chromodomain-helicase-DNA-binding protein 9 isoform X9
chromodomain-helicase-DNA-binding protein 9 isoform X16
chromodomain helicase DNA binding protein 9, transcript variant X20
chromodomain helicase DNA binding protein 9, transcript variant X21
chromodomain helicase DNA binding protein 9, transcript variant X25
chromodomain-helicase-DNA-binding protein 9 isoform X18
chromodomain-helicase-DNA-binding protein 9 isoform X19
chromodomain-helicase-DNA-binding protein 9 isoform X21
chromodomain helicase DNA binding protein 9, transcript variant X24
chromodomain-helicase-DNA-binding protein 9 isoform X20
chromodomain helicase DNA binding protein 9, transcript variant X26
chromodomain-helicase-DNA-binding protein 9 isoform X22
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: retinoblastoma-like protein 2
AKT interacting protein, transcript variant X2
AKT interacting protein, transcript variant X6
AKT interacting protein, transcript variant X4
AKT interacting protein, transcript variant X1
AKT interacting protein, transcript variant X5
AKT interacting protein, transcript variant X3
AKT interacting protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X1
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X3
alpha-ketoglutarate-dependent dioxygenase FTO isoform X1
alpha-ketoglutarate-dependent dioxygenase FTO isoform X2
alpha-ketoglutarate-dependent dioxygenase FTO isoform X3
iroquois homeobox 3, transcript variant X2
iroquois homeobox 3, transcript variant X1
iroquois-class homeodomain protein IRX-3 isoform X2
iroquois-class homeodomain protein IRX-3 isoform X1
uncharacterized LOC103306001, transcript variant X5
uncharacterized LOC103306001, transcript variant X3
uncharacterized LOC103306001, transcript variant X1
uncharacterized LOC103306001, transcript variant X4
uncharacterized LOC103306001, transcript variant X2
iroquois homeobox 5, transcript variant X1
iroquois homeobox 5, transcript variant X3
iroquois homeobox 5, transcript variant X2
iroquois homeobox 5, transcript variant X4
iroquois homeobox 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
iroquois homeobox 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
iroquois homeobox 5, transcript variant X7
iroquois-class homeodomain protein IRX-5 isoform X1
iroquois-class homeodomain protein IRX-5 isoform X2
iroquois-class homeodomain protein IRX-5 isoform X3
iroquois-class homeodomain protein IRX-5 isoform X4
iroquois homeobox 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
iroquois homeobox 6, transcript variant X2
iroquois homeobox 6, transcript variant X3
iroquois homeobox 6, transcript variant X5
iroquois homeobox 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
iroquois homeobox 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-6 isoform X2
iroquois-class homeodomain protein IRX-6 isoform X3
iroquois-class homeodomain protein IRX-6 isoform X4
iroquois-class homeodomain protein IRX-6 isoform X5
iroquois-class homeodomain protein IRX-6 isoform X1
iroquois-class homeodomain protein IRX-6 isoform X6
lysophosphatidylcholine acyltransferase 2, transcript variant X1
lysophosphatidylcholine acyltransferase 2 isoform X1
lysophosphatidylcholine acyltransferase 2, transcript variant X2
lysophosphatidylcholine acyltransferase 2 isoform X2
solute carrier family 6 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 6 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 6 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
sodium-dependent noradrenaline transporter
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 12 member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
solute carrier family 12 member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
probable ATP-dependent RNA helicase DDX28
dihydrouridine synthase 2, transcript variant X1
dihydrouridine synthase 2, transcript variant X3
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X1
dihydrouridine synthase 2, transcript variant X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X3
dihydrouridine synthase 2, transcript variant X4
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X4
uncharacterized LOC103305998, transcript variant X1
uncharacterized LOC103305998, transcript variant X2
nuclear factor of activated T cells 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor of activated T cells 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
nuclear factor of activated T cells 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
nuclear factor of activated T-cells, cytoplasmic 3 isoform X2
nuclear factor of activated T-cells, cytoplasmic 3 isoform X3
epithelial splicing regulatory protein 2, transcript variant X3
epithelial splicing regulatory protein 2, transcript variant X8
epithelial splicing regulatory protein 2, transcript variant X2
epithelial splicing regulatory protein 2, transcript variant X4
epithelial splicing regulatory protein 2, transcript variant X1
epithelial splicing regulatory protein 2 isoform X2
epithelial splicing regulatory protein 2 isoform X1
epithelial splicing regulatory protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X5
epithelial splicing regulatory protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
epithelial splicing regulatory protein 2 isoform X4
epithelial splicing regulatory protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
sphingomyelin phosphodiesterase 3, transcript variant X2
sphingomyelin phosphodiesterase 3, transcript variant X1
protein arginine methyltransferase 7, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein arginine N-methyltransferase 7 isoform X4
protein arginine methyltransferase 7, transcript variant X2
protein arginine methyltransferase 7, transcript variant X6
protein arginine methyltransferase 7, transcript variant X8
protein arginine methyltransferase 7, transcript variant X4
protein arginine methyltransferase 7, transcript variant X9
protein arginine methyltransferase 7, transcript variant X11
protein arginine methyltransferase 7, transcript variant X7
protein arginine methyltransferase 7, transcript variant X5
protein arginine methyltransferase 7, transcript variant X1
protein arginine methyltransferase 7, transcript variant X3
protein arginine methyltransferase 7, transcript variant X10
protein arginine N-methyltransferase 7 isoform X2
protein arginine N-methyltransferase 7 isoform X3
protein arginine N-methyltransferase 7 isoform X1
protein arginine methyltransferase 7, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
protein arginine methyltransferase 7, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
protein arginine N-methyltransferase 7 isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
solute carrier family 7 member 6 opposite strand
LOW QUALITY PROTEIN: probable RNA polymerase II nuclear localization protein SLC7A6OS
solute carrier family 7 member 6, transcript variant X2
solute carrier family 7 member 6, transcript variant X1
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X2
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X1
receptor-interacting serine/threonine-protein kinase 2-like isoform X2
receptor-interacting serine/threonine-protein kinase 2-like isoform X1
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X3
receptor-interacting serine/threonine-protein kinase 2-like isoform X3
oxidative stress induced growth inhibitor 1, transcript variant X1
oxidative stress induced growth inhibitor 1, transcript variant X3
oxidative stress induced growth inhibitor 1, transcript variant X2
oxidative stress-induced growth inhibitor 1
N-terminal EF-hand calcium binding protein 2, transcript variant X2
N-terminal EF-hand calcium binding protein 2, transcript variant X1
N-terminal EF-hand calcium-binding protein 2 isoform X1
N-terminal EF-hand calcium-binding protein 2 isoform X2
putative sodium-coupled neutral amino acid transporter 8
membrane bound transcription factor peptidase, site 1, transcript variant X2
membrane bound transcription factor peptidase, site 1, transcript variant X1
membrane-bound transcription factor site-1 protease isoform X2
membrane-bound transcription factor site-1 protease isoform X1
hydroxysteroid dehydrogenase like 1, transcript variant X4
hydroxysteroid dehydrogenase like 1, transcript variant X2
hydroxysteroid dehydrogenase like 1, transcript variant X3
hydroxysteroid dehydrogenase like 1, transcript variant X1
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X3
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X1
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X2
dynein axonemal assembly factor 1, transcript variant X4
dynein axonemal assembly factor 1, transcript variant X3
dynein axonemal assembly factor 1, transcript variant X1
dynein axonemal assembly factor 1, transcript variant X2
dynein axonemal assembly factor 1 isoform X1
dynein axonemal assembly factor 1 isoform X2
dynein axonemal assembly factor 1 isoform X3
dynein axonemal assembly factor 1 isoform X4
F-box and leucine rich repeat protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
F-box and leucine rich repeat protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
tumor necrosis factor receptor type 1-associated DEATH domain protein
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
phagosome assembly factor 1, transcript variant X3
phagosome assembly factor 1, transcript variant X2
phagosome assembly factor 1, transcript variant X6
phagosome assembly factor 1, transcript variant X4
phagosome assembly factor 1, transcript variant X5
phagosome assembly factor 1, transcript variant X1
core-binding factor subunit beta, transcript variant X4
core-binding factor subunit beta, transcript variant X3
core-binding factor subunit beta, transcript variant X2
core-binding factor subunit beta, transcript variant X1
core-binding factor subunit beta isoform X3
core-binding factor subunit beta isoform X4
core-binding factor subunit beta isoform X1
core-binding factor subunit beta isoform X2
G protein subunit alpha o1, transcript variant X2
G protein subunit alpha o1, transcript variant X3
G protein subunit alpha o1, transcript variant X1
guanine nucleotide-binding protein G(o) subunit alpha isoform X1
guanine nucleotide-binding protein G(o) subunit alpha isoform X2
autocrine motility factor receptor, transcript variant X2
autocrine motility factor receptor, transcript variant X1
autocrine motility factor receptor, transcript variant X3
autocrine motility factor receptor, transcript variant X4
E3 ubiquitin-protein ligase AMFR isoform X3
E3 ubiquitin-protein ligase AMFR isoform X2
E3 ubiquitin-protein ligase AMFR isoform X1
E3 ubiquitin-protein ligase AMFR isoform X4
cleavage and polyadenylation specificity factor subunit 5
2-oxoglutarate and iron dependent oxygenase domain containing 1
nuclear pore complex protein Nup93 isoform X1
nuclear pore complex protein Nup93 isoform X2
solute carrier family 12 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
solute carrier family 12 member 3, transcript variant X1
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X3
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X4
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X3
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X4
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X1
homocysteine inducible ER protein with ubiquitin like domain 1, transcript variant X2
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X1
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X2
cholesteryl ester transfer protein, transcript variant X1
cholesteryl ester transfer protein, transcript variant X2
cholesteryl ester transfer protein isoform X1
cholesteryl ester transfer protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns